Compare key investment metrics of 보령 and 삼성제약 in real time. Both stocks belong to the 흑사병(페스트) 관련주 sector. View PER (Price-to-Earnings Ratio), PBR (Price-to-Book Ratio), dividend yield, market capitalization, and 52-week high/low side by side, with automatic highlighting of the leading stock for each metric.
Comparison at a Glance
- By market capitalization, 보령 is larger — ₩721B vs 삼성제약's ₩125B. Larger companies tend to be less volatile, while smaller ones may offer more growth headroom.
- 보령's current price of 8,400원 sits at about 22% of its 52-week range (7,580원–11,350원).
- 삼성제약's current price of 1,331원 sits at about 9% of its 52-week range (1,230원–2,320원).
- This comparison is for reference only, based on publicly available market data, and does not constitute investment advice.
| Metric | 보령 | 삼성제약 |
|---|---|---|
| Price | 8,400원 | 1,331원 |
| PER | 6.83배 | - |
| PBR | 0.81배 | 0.97배 |
| Dividend Yield | 1.91% | - |
| Market Cap | ₩721B | ₩125B |
| 52-Week High | 11,350원 | 2,320원 |
| 52-Week Low | 7,580원 | 1,230원 |
As of 2026-07-06 · Source: KRX (Naver Finance) public data
Frequently Asked Questions
Which has a lower PER, 보령 or 삼성제약?
PER (Price-to-Earnings Ratio) divides a stock's price by its earnings per share. A lower PER may suggest the stock is undervalued relative to its earnings. Since PER changes with each earnings report, check the real-time comparison table on this page for the latest 보령 and 삼성제약 PER values.
What is the dividend yield difference between 보령 and 삼성제약?
Dividend yield measures annual dividends as a percentage of the stock price. A higher yield means more cash income per dollar invested. The dividend yields of 보령 and 삼성제약 fluctuate with dividend policy changes and stock price movements — check this page's live data for the most current comparison.
How to compare 보령 and 삼성제약?
PFlow's stock comparison page lets you compare key investment metrics side by side — PER, PBR, dividend yield, market cap, and 52-week high/low. Each metric automatically highlights which stock has the advantage. For deeper analysis, visit each stock's dedicated detail page.